Story perspectives

Senate Hearing Delayed as Trump's Surgeon General Nominee Faces Psychedelic Scrutiny

2/26/2026

Summary

Story summary

During the Feb. 25, 2026 Senate confirmation hearing, Sen. Susan Collins (R-ME) questioned Dr. Casey Means, President Donald Trump’s surgeon general nominee, about past use of psychedelics.
Collins cited Means's psilocybin endorsement in Good Energy and noted addiction and overdose concerns.
Means said her views differ from her public health role, and she would not recommend psilocybin.
The hearing was delayed due to Means's labor during the originally scheduled session.

1 of 1

Story summary

During the Feb. 25, 2026 Senate confirmation hearing, Sen. Susan Collins (R-ME) questioned Dr. Casey Means, President Donald Trump’s surgeon general nominee, about past use of psychedelics.
Collins cited Means's psilocybin endorsement in Good Energy and noted addiction and overdose concerns.
Means said her views differ from her public health role, and she would not recommend psilocybin.
The hearing was delayed due to Means's labor during the originally scheduled session.